This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Upgrades for Allergan and Chipotle, Amazon Downgraded

In Tuesday's Analysts' Actions, calls on Allergan, Chipotle and Amazon.

Public PE Firms Rebound After Under-Performing for Most of 2014

The shares prices of publicly traded private equity firms posted a disappointing performance for most of the first half of 2014.

U.S. Stocks Rebound on Encouraging Earnings and Economic Data

U.S. markets rebounded on Tuesday after Monday's losses on better than expected Q2 results from big names and positive economic data.

McDonald's Global Sales Stall in Q2, Profits Miss Forecasts

Share of McDonald's are down on Tuesday after it missed forecasts. One key reason for the shortfall: U.S. stores under-performed.

Verizon Q2 Sales Beat, Gets 1.4 Million More Contract Subscribers

Verizon posted second quarter results that topped forecasts in the second quarter on the back of contract subscriber growth.

Real Money Previews

Williams: Shorting Tesla's Batteries

The upside seems limited; the downside seems limitless.

Gad: The Next Google-Like IPO

Alibaba's public offering will be a rare buying opportunity.

Cramer: Four Stocks to Lift Your Spirits

These four companies have one thing in common: optimism.

Mad Money Recap

'Mad Money' Lightning Round: Buy, Buy, Buy Reynolds American

Cramer is bullish on Sunoco Logistics Partners and Sanchex Energy but he would not own Tumi Holdings.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Defense Stocks to Trade for Gains This Week

Defense contractors are starting to show some signs of life again. Here are five to trade now.

3 Stocks Rising on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

4 Hot Stocks to Trade (or Not)

Here's how to trade some of the most active stocks on the market today.

3 Huge Tech Stocks on Traders' Radars

Here's how to trade some of the most active tech stocks on the market today.

MainStreet

Despite Bad News on Housing Market, Outlook is Positive for 2014

News about volatility in the the U.S. real estate market looks like cause for concern, but a little analysis paints a more reassuring picture.

7 Ways to Cope When You Lose a Job Suddenly

Workers who prepare their finances ahead of time can weather a period of unemployment and hold out for a new job they really want.

5 Approaches to Health That Will Hurt You

Our health as a nation may be improving thanks to the Affordable Care Act, but that won't help much if individuals don't stop their bad habits.

Price Hike For Adding a Teen Driver To Insurance? 79%

Living in some states can really dent your wallet with a teen driver, with New Hampshire being the worst. The sole state that won't punish you? Hawaii.

Nearly 70% of U.S. Consumers Want Their Chip-and-PIN Credit Cards

Plenty of Americans are using cashing while safer, higher-security cards await their rollout.

Biotech

Galena Gives Sales Team Another Useless Product to Promote

Galena stands little chance of delivering higher sales of Zuplenz than its previous marketer.

Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Buying Bluebird's Blockbuster Potential at a Discount

It's not often an investor gets the opportunity to buy a biotech stock with two blockbuster indications in the pipeline and major catalysts only months away at such a discount.

Beyond Wall St.

Deal News

Public PE Firms Rebound After Under-Performing for Most of 2014

The shares prices of publicly traded private equity firms posted a disappointing performance for most of the first half of 2014.

CIT Group Inks $3.4B OneWest Deal

Southern California target was seized by FDIC in 2009, sold to group including Flowers, Paulson and Soros.

Allergan Reiterates Plan to Preempt Valeant Offer

Allergan is sticking to script with its second quarter earnings, announcing that it will continue on a cost reduction regime and will execute a merger.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer Answers Twitter Questions on ADP, BP and Time Warner

Jim Cramer responds to viewers' questions on Twitter from the floor of the New York Stock Exchange.

Herb Greenberg

Greenberg: Allergan's Dilemma

Allergan is in a tight spot: It had better hope, if it's successful fighting off Valeant, that its stock price doesn't tumble -- and in a year has rebounded!

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Apple's Ho-Hum Quarter Is a Set-Up to Its Biggest Product Launch Ever

Apple shares have surged since it reported fiscal second-quarter earnings, and investors will be looking to see whether the iPhone units continue to be strong ahead of a refresh.

Adam Feuerstein

Galena Gives Sales Team Another Useless Product to Promote

Galena stands little chance of delivering higher sales of Zuplenz than its previous marketer.

Laurie Kulikowski

Chipotle Is a 'Once-in-a-Decade' Brand: Analyst

Fast-casual burrito chain Chipotle proved once again that it is in a league of its own when it comes to restaurant stocks. Here's what Wall Street was saying on Tuesday.

Dan Freed

Barclays Charged With Fraud Over 'Dark Pool'

Barclays Capital committed fraud tied to a private, internal stock trading platform known as a 'dark pool,' according to charges filed Wednesday by New York Attorney General Eric S...

Rocco Pendola

Why Yahoo's Marissa Mayer Is 2014's Top CEO By a Landslide

Tech geeks and financial media wonks focus on the wrong factors at Yahoo. Pay attention to Yahoo! Screen -- it will become Mayer's game-changing legacy.

Ted Reed

JetBlue, With Expectations Low, Could Face Changes

JetBlue should be benefiting from the relative strength of its domestic markets. It's not.

Leon Lazaroff

Aereo Loses as Supreme Court Rules Service Violates Copyright Law

Aereo's future was put in doubt as the Supreme Court ruled that the video-streaming service violates U.S. copyright law.

Submit an article to us!
DOW 17,115.04 +63.31 0.37%
S&P 500 1,984.69 +11.06 0.56%
NASDAQ 4,458.5880 +33.8840 0.77%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs